Diabetes

 

Thursday, September 08, 2005

New Class of Diabetes Drug to Be Considered


New Class of Diabetes Drug to Be Considered by FDA
Diabetes Self Management - 12 hours ago On September 9, a new Type 2 diabetes drug called muraglitazar (brand name Pargluva) will be reviewed by the Food and Drug Administration's Endocrinologic and

Pfizer�s inhaled diabetes drug clears hurdle
Financial Times, UK - 4 hours ago Pfizer on Thursday cleared a hurdle for Exubera, the first inhaled insulin treatment for diabetes, when a US medicines regulatory advisory panel recommended

Source: Complete Care Medical, Inc.
PrimeZone (press release), CA - 5 hours ago HOUSTON, Sept. 8, 2005 (PRIMEZONE) -- Complete Care Medical, Inc., (Pink Sheets:CCMI), today announced that its wholly owned subsidiary, Diabetes Gold, Inc.

Generex Biotechnology Immunotherapeutics Subsidiary to Present at
PR Newswire (press release), NY - 1 hour ago immunotherapeutics subsidiary, will make the following presentations at the 41st Annual Meeting of the European Association for the Study of Diabetes (EASD) to

Medical Minute: Surviving Diabetes in a Disaster
WSAW, WI - 6 hours ago Type one diabetes is an autoimmune disorder which means a diabetic�s body can't fight bacteria as well as a non-diabetic. Diane

posted by healthwa @ 9:00 PM